Search

Author/Creator Feng, M

2. 280TiPGOG 3016/ENGOT-cx9: An open-label, multi-national, randomized, phase III trial of cemiplimab, an anti-PD-1, versus investigator's choice (IC) chemotherapy in ≥ second-line recurrent or metastatic cervical cancer. (25th November 2018)

Authors:
Tewari, K S; Vergote, I; Oaknin, A; Alvarez, E; Gaillard, S; Lheureux, S; Rischin, D; Santin, A D; Feng, M; Mathias, M; Fury, M; Lowy, I; Monk, B J
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 9
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 75PCemiplimab, a human PD-1 monoclonal antibody, in patients (pts) with recurrent or metastatic cervical cancer: Interim data from phase I cohorts. (17th December 2018)

Authors:
Rischin, D; Gil-Martin, M; González-Martin, A; Brana, I; Hou, J Y; Cho, D; Falchook, G; Formenti, S; Jabbour, S; Moore, K; Naing, A; Papadopoulos, K P; Baranda, J; Weise, A; Fury, M G; Feng, M; Li, J; Lowy, I; Mathias, M
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 10
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. 74PPhase I expansion cohort results of cemiplimab, a human PD-1 monoclonal antibody, in combination with radiotherapy (RT), cyclophosphamide and GM-CSF, in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC). (17th December 2018)

Authors:
Babiker, H M; Brana, I; Mahadevan, D; Owonikoko, T K; Calvo, E; Rischin, D; Moreno, V; Papadopoulos, K P; Crittenden, M; Formenti, S; Giralt, J; Garrido, P; Hervás Morón, A; Mohan, K K; Fury, M G; Lowy, I; Stankevich, E; Feng, M; Li, J; Mathias, M
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 10
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. 73PCemiplimab, a human monoclonal anti-PD-1, in patients (pts) with advanced or metastatic hepatocellular carcinoma (HCC): Data from an expansion cohort (EC) in a phase I study. (17th December 2018)

Authors:
He, A R; Weiss, G J; Falchook, G; Yee, N S; Gil-Martin, M; Shahda, S; Moreno, V; Brana, I; Crittenden, M; Formenti, S; Al-Rajabi, R; Papadopoulos, K P; Pishvaian, M J; Stankevich, E; Feng, M; Li, J; Mathias, M; Kroog, G; Lowy, I; Fury, M G
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 10
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. 1151PCemiplimab, a human monoclonal anti-PD-1, in patients (pts) with advanced or metastatic hepatocellular carcinoma (HCC): Data from an expansion cohort in a phase I study. (23rd October 2018)

Authors:
Pishvaian, M J; Weiss, G J; Falchook, G S; Yee, N; Gil-Martin, M; Shahda, S; Moreno, V; Brana, I; Crittenden, M; Formenti, S; Al-Rajabi, R; Papadopoulos, K P; Stankevich, E; Feng, M; Li, J; Mathias, M; Kroog, G; Lowy, I; Fury, M G
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. 72PCemiplimab, a human monoclonal anti-PD-1, plus radiotherapy (RT) in advanced non-small cell lung cancer (NSCLC): Results from a phase I expansion cohort (EC 2). (17th December 2018)

Authors:
Moreno, V; Gil-Martin, M; Johnson, M L; Aljumaily, R; Lopez Criado, P; Northfelt, D W; Crittenden, M; Jabbour, S; Rosen, L; Garrido, P; Hervás Morón, A; Rietschel, P; Mohan, K K; Li, J; Stankevich, E; Feng, M; Lowy, I; Fury, M G
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 10
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. 1162PCemiplimab, a human monoclonal anti-PD-1, plus radiotherapy (RT) in advanced non-small cell lung cancer (NSCLC): Results from a phase I expansion cohort (EC 2). (23rd October 2018)

Authors:
Moreno, V; Gil-Martin, M; Johnson, M; Aljumaily, R; Lopez Criado, P; Northfelt, D W; Crittenden, M; Jabbour, S; Rosen, L; Garrido Lopez, P; Hervás Morón, A; Rietschel, P; Mohan, K K; Li, J; Stankevich, E; Rowlands, T; Feng, M; Lowy, I; Fury, M G
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. P1007Combined therapy with left atrial appendage closure plus catheter ablation in a single procedure for patients with nonvalvular atrial fibrillation: chinese multi-center experience. (28th August 2018)

Authors:
Du, X; Chu, H; Ye, P; He, B; Xu, H; Jiang, S; Lin, M; Lin, R; Liu, J; Wang, B; Feng, M; Yu, Y; Chen, X
Journal:
European heart journal
Issue:
Volume 39(2018)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗